Predictive cytokine biomarkers for survival in patients with advanced pancreatic cancer randomized to sequential chemoimmunotherapy comprising gemcitabine and capecitabine (GemCap) followed by the telomerase vaccine GV1001 compared to concurrent chemoimmunotherapy in the TeloVac phase III trial.
2014 ◽
Vol 32
(15_suppl)
◽
pp. 4121-4121
◽
2007 ◽
Vol 25
(16)
◽
pp. 2212-2217
◽
2005 ◽
Vol 23
(16_suppl)
◽
pp. 4105-4105
◽
Keyword(s):
2010 ◽
Vol 28
(15_suppl)
◽
pp. 4079-4079
Keyword(s):
2004 ◽
Vol 22
(14_suppl)
◽
pp. 4006-4006
◽
Keyword(s):
2021 ◽
Vol 39
(15_suppl)
◽
pp. 4119-4119
2010 ◽
Vol 28
(10)
◽
pp. 1645-1651
◽
Keyword(s):
Keyword(s):
2004 ◽
Vol 22
(14_suppl)
◽
pp. 4006-4006
◽
Keyword(s):